These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28848102)

  • 1. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
    Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
    Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder.
    Shen Z; Lu Y; Jiang H; Ye J; Zhou C; He M; Li N; Xu X; Cheng Y
    Neuroreport; 2020 Nov; 31(16):1146-1153. PubMed ID: 32991522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
    Katsuki A; Yoshimura R; Kishi T; Hori H; Umene-Nakano W; Ikenouchi-Sugita A; Hayashi K; Atake K; Iwata N; Nakamura J
    CNS Spectr; 2012 Sep; 17(3):155-63. PubMed ID: 22883353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
    Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
    Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
    Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
    World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
    Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome.
    Cardoner N; Soria V; Gratacòs M; Hernández-Ribas R; Pujol J; López-Solà M; Deus J; Urretavizcaya M; Estivill X; Menchón JM; Soriano-Mas C
    Depress Anxiety; 2013 Mar; 30(3):225-33. PubMed ID: 23165919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
    Kanellopoulos D; Gunning FM; Morimoto SS; Hoptman MJ; Murphy CF; Kelly RE; Glatt C; Lim KO; Alexopoulos GS
    Am J Geriatr Psychiatry; 2011 Jan; 19(1):13-22. PubMed ID: 21218562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.
    Suchanek R; Owczarek A; Kowalczyk M; Kucia K; Kowalski J
    J Mol Neurosci; 2011 Mar; 43(3):524-30. PubMed ID: 21103954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course.
    Miller S; Hallmayer J; Wang PW; Hill SJ; Johnson SL; Ketter TA
    J Psychiatr Res; 2013 Feb; 47(2):252-8. PubMed ID: 23182421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain.
    Lan MJ; Ogden RT; Huang YY; Oquendo MA; Sullivan GM; Miller J; Milak M; Mann JJ; Parsey RV
    Neuroimage; 2014 Jul; 94():33-39. PubMed ID: 24607934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
    Froud A; Murphy J; Cribb L; Ng CH; Sarris J
    Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.
    Ozan E; Okur H; Eker C; Eker OD; Gönül AS; Akarsu N
    Brain Res Bull; 2010 Jan; 81(1):61-5. PubMed ID: 19589373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF Val66Met genetic variation and its plasma level in patients with morbid obesity: A case-control study.
    Zamani M; Hosseini SV; Behrouj H; Erfani M; Dastghaib S; Ahmadi M; Shamsdin SA; Mokarram P
    Gene; 2019 Jul; 705():51-54. PubMed ID: 31004714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
    Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
    Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.
    Pathak P; Mehra A; Ram S; Pal A; Grover S
    Behav Brain Res; 2022 Jul; 430():113931. PubMed ID: 35605794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients.
    Iga J; Ueno S; Yamauchi K; Numata S; Tayoshi-Shibuya S; Kinouchi S; Nakataki M; Song H; Hokoishi K; Tanabe H; Sano A; Ohmori T
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1003-6. PubMed ID: 17510948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.